Cigna Corp vs Salesforce Inc — how do they compare? Cigna Corp trades at $294.92 (market cap $77.36B), while Salesforce Inc trades at $215.53 (market cap $175.83B). The key difference: Salesforce Inc is far larger — about 2.3× Cigna Corp's market cap, and Cigna Corp pays the higher dividend (2.13%). Which is the better fit depends on your goals — on Pluang, investors hold Cigna Corp for 67 Days and Salesforce Inc for 89 Days on average.
| CI | CRM | |
|---|---|---|
Market Cap | $77.36B | $175.83B |
Volume | 2,427,971 | 6,706,563 |
Sector | Health | Technology |
52-Week High | $315.88 | $266.23 |
52-Week Low | $257.97 | $150.12 |
Typical Hold Time | 67 Days | 89 Days |
Enterprise Value | $101.28B | $206.17B |
Dividend Yield | 2.13% | 0.82% |
Signals from Pluang's Aura AI — not financial advice
Cigna Group (CI) trades at $293.59, down 2.62% on the day, with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals with a P/E of 12.96 and P/S of 0.27, indicating potential undervaluation. Recent quarterly earnings have consistently beaten expectations, and the company maintains a 70% analyst buy rating with a $342.08 consensus price target. Cigna's $3 billion AI investment initiative and focus on specialty pharmacy growth highlight strategic positioning.
The investment case for CI centers on attractive valuation metrics, consistent earnings outperformance, and strategic growth initiatives in complex care and AI. Key risks include healthcare cost pressures and execution challenges in technology integration. With solid institutional support and positive analyst sentiment, the stock presents a compelling opportunity for value-oriented investors seeking exposure to the healthcare sector.
Salesforce (CRM) trades at $215.45, up 0.84% with strong fundamentals including 77.28% gross margins and consistent earnings beats. The stock faces technical headwinds with bearish signals across moving averages and oscillators, trading near support at $214. Recent AI-driven growth initiatives show promise with Agentforce and Data 360 ARR reaching $2.9 billion, though sector-wide software selloffs have pressured valuations.
Wall Street maintains bullish sentiment with 76.5% buy ratings and $274.18 consensus target, representing 27% upside. Key risks include AI competition and macroeconomic volatility, but strong cash flow generation and expanding profit margins support long-term growth prospects despite near-term technical weakness.
Trailing returns across standard periods
Latest headlines on both assets
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →